Correlation Between Genmab AS and Ambu AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Ambu AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Ambu AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Ambu AS, you can compare the effects of market volatilities on Genmab AS and Ambu AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Ambu AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Ambu AS.

Diversification Opportunities for Genmab AS and Ambu AS

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Genmab and Ambu is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Ambu AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ambu AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Ambu AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ambu AS has no effect on the direction of Genmab AS i.e., Genmab AS and Ambu AS go up and down completely randomly.

Pair Corralation between Genmab AS and Ambu AS

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Ambu AS. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 1.44 times less risky than Ambu AS. The stock trades about -0.07 of its potential returns per unit of risk. The Ambu AS is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  12,921  in Ambu AS on November 1, 2024 and sell it today you would earn a total of  1,019  from holding Ambu AS or generate 7.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Ambu AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Ambu AS 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ambu AS are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental drivers, Ambu AS may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Genmab AS and Ambu AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Ambu AS

The main advantage of trading using opposite Genmab AS and Ambu AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Ambu AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambu AS will offset losses from the drop in Ambu AS's long position.
The idea behind Genmab AS and Ambu AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes